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CORRESPONDENCE
I feel you-monitoring environmental 




The study of asthma and other complex diseases has proven to be a “moving target” for researchers due to its com-
plex aetiology, difficulty in definition, and immeasurable environmental effects. A large number of studies regarding 
the contribution of both genetic and environmental factors often result in contradictory results, in part due to the 
highly heterogeneous nature of asthma. Recent literature has focused on the epigenetic signatures of asthma caused 
by environmental factors, highlighting the importance of environment. However, unlike the genetic techniques, 
environmental assessment still lacks accuracy. A plausible solution for this problem would be an individual-based 
environmental exposure assessment, relying on new technologies such as personal real-time environmental sensors. 
This could prove to enable the assessment of the whole environmental exposure—or exposome—matching in terms 
of precision the genome that is emphasized in most studies so far. In addition, the measurement of the whole array 
of biological molecules, in response to the environment action, could help understand the context of the disease. 
The current perspective comprises a beyond-genetics integrated vision of omics technology coupled with real-time 
environmental measures targeting to enhance our comprehension of the disease genesis.
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Discussion
Asthma is a complex disease influenced by the interac-
tion of multiple environmental and genetic factors. It is 
defined as a chronic inflammation that narrows the air-
ways, causing airflow obstruction, leading to wheezing, 
chest tightness and coughing [1]. The disease affects 
more than 235 million people worldwide [2] and it was 
responsible for 255,000 deaths in 2005, according to the 
World Health Organization [3].
Asthma is an ever-growing pathology especially in the 
westernized world, and a large number of studies assess-
ing the contribution of both genetic and environmental 
factors to the disease aetiology have been reported [4–8].
However, the results are often contradictory. As an 
example, the association of the polymorphism C-589T 
in the promoter region of the interleukin 4 gene (IL4) 
(rs2243250) to asthma has been inconsistent across dif-
ferent populations, despite its biological plausibility as a 
candidate gene [9]. On the other hand, the GSDML-236 
(rs7216389) SNP, whose biological role was unknown at 
the time of its discovery, has been successfully replicated 
as associated to different asthma phenotypes across a 
number of studies [10–20].
But even among statistically robust GWA studies, non-
replication and inconsistencies are still an issue [21]. In 
fact, GWA analyses may not capture all relevant varia-
tion, such as rare variants thought to have larger pheno-
typic effects than common variants. In addition, GWAs 
statistical approach may not be adequate to model the 
polygenic nature of asthma as well as its gene –environ-
ment interactions [22]. Similarly, on the environmental 
aspect, the effect of motor air pollution on asthma in chil-
dren has also produced conflicting results [23]. Distinct 
study designs, dissimilar asthma definitions, different 
environmental setting and diverse genetic backgrounds 
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are amongst the main explanations for the lack of con-
sistency between studies [24–26].
Moreover, asthma is a highly heterogeneous disease 
where various phenotypes can be defined, such as early-
onset allergic asthma, late-onset eosinophilic, exercise-
induced, obesity related and neutrophilic asthma [27]. 
Asthma endotypes have also been proposed as a way to 
break down the disease according to its pathophysiologi-
cal mechanism. For instance, within a specific pheno-
type, as obesity-related asthma, a number of endotypes 
can emerge (airflow obstruction caused by obesity, severe 
steroid-dependent asthma, severe late-onset hypereosin-
ophilic asthma, etc.) [28]. But, again, within an endotype, 
the disease severity can vary [28] adding to the complex-
ity of the definition. Under these circumstances, new 
approaches for understanding the disease are needed.
We have recently proposed that rather than as a snap-
shot, asthma should be considered as a motion picture 
across evolution and in permanent interaction with its 
surrounding environment [29].
This becomes particularly relevant when one consid-
ers two key aspects: the significant increase of asthma 
in developed societies over the last two decades, and the 
epigenetic effects of certain environmental exposure over 
asthma.
Numerous examples of epigenetic effects over DNA, 
as a result of air pollution, have recently appeared in lit-
erature. For example, methylation levels in the promoter 
of NPSR1 gene, relate to asthma in children and adults 
as a result of smoking exposure [30]. High methylation 
levels in the 5′ UTR of ADRB2 gene also relate to severe 
childhood asthma, in association with indoor exposure 
to NO2 [31]. Particulate matter with aerodynamic diam-
eter ≤2.5 μm (PM2.5) has been found to influence iNOS 
methylation pattern, affecting FeNO levels, a predictor 
for the future risk of asthma and wheeze [32]. Meth-
ylation patterns in a number of genes included in the 
asthma pathway were found associated to specific air-
borne particulate matter like black carbon (HLA-DOB, 
FCER1A, IL9, and PRG2), sulphate (HLA-DPA1, IL-10, 
RNASE3, CCL11) or both (FCER1G) [33]. Exposure to 
inhaled diesel particles and allergen have been found to 
induce hypomethylation within a CpG−408 site of the IL4 
gene promoter, correlating to IgE production, central to 
the pathophysiology of asthma [34]. Finally, hypermeth-
ylation of the FOXP3 gene was observed in the regulatory 
T cells of asthmatic children exposed to high air pollu-
tion, as opposed to the ones subjected to low levels [35]. 
For most of these studies, the assessment of air pollution 
exposure was performed based either on questionnaires 
[30], seasonal collecting [31] or on nearby central moni-
toring sites in the study community [32, 33]. For the lat-
ter, in the case of absence of data, the gaps were filled by 
using data from nearby monitors [32]. Although these 
studies require further validation in larger samples, they 
provide an opportunity for reflexion on current practices 
pertaining environmental assessment.
Such environmental exposure assessments have certain 
drawbacks. The use of questionnaires, for example, may 
lead to the misclassification of exposure due to the par-
ticipant’s difficulty in recalling exposure in a precise way, 
recall bias or even intentional false reporting of exposure 
[36]. Seasonal monitoring implies that exposure is only 
monitored in a discrete time frame, which means that a 
great deal of data is excluded. Finally, monitoring based 
on nearby sites also has downsides. Although monitoring 
can be estimated on a daily basis, gaps in the data moni-
toring may occur; in addition, this kind of monitoring 
assumes that the type and degree of exposure is exactly 
the same for distinct individuals living in the same spa-
tio-temporal setting.
However, sensitive differences in individual exposure 
might occur that do not coincide with each other and/
or with the ones reported for the surrounding environ-
ment. For example, a recent study found that the individ-
ual exposure to NO2 in a group of healthy adults living in 
Stockholm was significantly different than the one meas-
ured for the urban background level (13 versus 20  µg/
m3). Time-activity patterns such as time spent at home 
and at the workplace explain part of the variation [37].
In this context, the development of an individual-based 
assessment of exposure to environmental factors could 
prove of crucial importance to understanding the dynam-
ics of complex diseases such as asthma [38].
An increasing body of literature has proposed the use of 
new technologies, like mobile devices in personal health 
monitoring [39–41] and, in particular, for assessing and 
self-managing asthma [42, 43]. However, most of these 
approaches are purely based either on phone calls [42] or 
text messaging [43] failing to provide a broader context 
for the disease study. An increasing number of apps for 
smartphones and tablets aimed to support asthma self-
management exist nowadays, but they still lack reliabil-
ity and accuracy and fail to provide the patient with the 
comprehensive information about the condition neces-
sary for self-management [44].
Research-wise, mobile devices such as smartphones 
equipped with a GPS system can provide data on time 
and location of the patients. In parallel, they can use 
wireless sensor to record environmental variables (such 
as the level of humidity or smoke concentration, etc.), 
and also monitor certain physiological signals to help 
predict the causes of acute asthma episodes [38].
Examples of both environmental and health personal 
sensors exist. A research team has recently developed a 
real-time second and third-hand smoke sensor prototype 
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that measures and records smoke through the adsorption 
of ambient nicotine vapor [45]. Electrochemical in  vivo 
sensors, which offer near real-time measurement of ana-
lytes, have also been improved in the last decades and are 
now used to detect a range of in vivo targets such as glu-
cose, glutamate, reactive nitrogen species and many neu-
rochemicals [46].
Although there are still some limitations to the use of 
mobile devices for this particular kind of sensing, such 
as battery life, wireless coverage [47], and sensor syn-
chronisation [38], technological advances in the area of 
Ubiquitous Computing are rapidly improving, leading to 
an endless sphere of applications, with great potential for 
public health research.
Thus, one of the current goals is the real-time moni-
toring of the environmental factors that affect disease. 
From a general perspective, in most gene-environment 
studies, genotyping has been emphasized in comparison 
to environmental assessment because genotyping tech-
niques are accurate and systematic, while environmental 
exposure measures still lack precision [48]. Focusing on 
this asymmetry, the term “exposome” was coined back 
in 2005, referring to the concept of assessing one’s life-
course environmental exposures (including lifestyle fac-
tors) from the prenatal period onwards [49].
Currently, a number of large-scale projects are focused 
on addressing and developing tools to evaluate the whole 
environmental exposure and its impact on human health 
[50–53]. The Human Exposome Project intends to evalu-
ate a number of environmental exposures, from diet to 
lifestyle and behaviour, combined with genetics and medi-
cine in order to prevent and treat a number of diseases 
[50]. Similarly, the HELIX project, aims to measure pre-
natal and postnatal exposure to a variety of chemical and 
physical variables by using smartphone linked sensors, as 
well as omics techniques to determine molecular profiles 
related to exposure [51]. The EXPOsOMICS project, tar-
gets to assess the exposome through a personal exposure 
monitoring system, including sensors, smartphones, geo-
referencing and satellites, and will also look into biological 
samples for internal makers of external exposure, through 
omics technologies [52]. Finally, the HEALS project 
focuses on assessing individual exposure to conventional 
and emerging environmental stressors, using a range of 
novel technologies, such as mobile phone apps, coupled 
with DNA sequencing, epigenetic DNA modifications, and 
gene expression aimed to assess disease phenotypes [53].
The word “-omics” refers to the thorough study of sets 
of biological molecules with high-throughput techniques 
providing a more comprehensive analysis of biological 
systems [54]. Some omics technologies in environmental 
health include transcriptomics, epigenomics, proteomics 
and metabolomics [54].
The current focus on the real-time assessment of the 
exposome, and the inclusion of omics analysis clearly 
aims for an integrative vision of disease as the result of 
individual susceptibility to exposure. Rather than the 
traditional nature versus nurture paradigm, the cur-
rent model integrates both concepts, leading to a nature 
et nurture coordinated approach, that can significantly 
advance our understanding of complex non-communica-
ble diseases, like asthma.
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